Trade AbbVie ABBV

AbbVie live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

AbbVie news

Tommy Yap 2025 Apr 19, 16:00

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Forex Indices
Federal Reserve Rate Decision 
Darius Anucauskas 2025 Jan 25, 16:00

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Forex Indices
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Neil Wilson 2023 Jul 21, 00:09

Week ahead: Fed, ECB & BoJ in action

Forex Indices

Latest news

Show more
Tommy Yap 2025 Jul 12, 21:00

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

Forex Indices
N/A
Ava Grace 2025 Jul 11, 09:21

EU-US Trade Talks: Progress, Challenges, and Future Prospects

N/A
Emma Rose 2025 Jul 11, 09:21

Elon Musk, Tesla Stock, and Political Ambitions: A Rocky Road Ahead?

N/A
Noah Lee 2025 Jul 11, 09:21

Iranian President Claims Israel Attempted Assassination Amidst Nuclear Program Tensions

N/A
Sophia Claire 2025 Jul 11, 09:20

Fed Debate Heats Up: Navigating Trump Tariffs and Interest Rate Decisions

N/A
Emma Rose 2025 Jul 11, 09:20

Trump's Tariff Barrage: Brazil Faces 50% Levy and Market Jitters

N/A
liam james 2025 Jul 11, 09:20

Fed Minutes: Tariffs, Inflation, and the Interest Rate Outlook

N/A
liam james 2025 Jul 11, 09:20

OpenAI's AI-Powered Browser: A Challenge to Google Chrome's Dominance

Info

Spread

1.24

Spread (%)

0.6466 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

339943686144

Shares Outstanding

1766400000

Earnings Date (Next)

0000-00-00

instr__dividend_date

2025-08-15

instr__ex_dividend_date

2025-07-15

instr__forward_annual_dividend_rate

6.56

instr__forward_annual_dividend_yield

0.0353

EPS

2.35

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot